Microglía, astrocitos, citocinas e inflamasomas — Alzheimer, Parkinson, Esclerosis Múltiple
| Mecanismo | Alzheimer | Parkinson | Esclerosis Múltiple |
|---|---|---|---|
| Célula efectora principal | Microglía M1 | Microglía activada | Linfocitos T CD4+ |
| Desencadenante | Depósito Aβ | α-Sinucleína | Autoantígenos mielina |
| Inflamasoma | NLRP3 | NLRP3 | No predominante |
| Citocina más elevada | IL-1β (8.8x) | IL-6 (9.3x) | IFN-γ (24.8x) |
| Barrera hematoencefálica | Disruption tardía | Moderada | Disruption temprana |
| Diana terapéutica activa | Microglía/TNF-α | α-Sinucleína/LRRK2 | BTK/IL-17/IL-6 |
APA: de la Serna, J. M. (2026). Neuroinflammation and Neurodegenerative Disorders: Integrated Molecular Biomarkers, Neuroimaging and Clinical Progression Data. Harvard Dataverse. https://doi.org/10.7910/DVN/X2TQQA
@dataset{delaserna2026neuro,
author={de la Serna, Juan Moises},
title={Neuroinflammation and Neurodegenerative Disorders: Integrated Molecular Biomarkers, Neuroimaging and Clinical Progression Data},
year={2026},
publisher={Harvard Dataverse},
doi={10.7910/DVN/X2TQQA},
url={https://doi.org/10.7910/DVN/X2TQQA}
}